Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Frederik Ivars
Introduction
Frederik Ivars is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of therapeutic compounds through his innovative research and patent work. His expertise lies in the modulation of protein interactions, which has important implications for medical therapies.
Latest Patents
Frederik Ivars holds a patent for the "S100A9 interaction screening method." This method identifies compounds that can modulate the interaction of S100A9 with ligands. The patent outlines a process for determining whether a candidate compound can affect the binding of S100A9 with RAGE or Toll-like receptors (TLRs). This innovative approach is crucial for identifying potential therapeutic compounds.
Career Highlights
Ivars is associated with Active Biotech AB, a company focused on developing innovative therapies. His work at the company has been instrumental in advancing research in the field of immunology and therapeutic development. With one patent to his name, he has established himself as a key figure in his area of expertise.
Collaborations
Frederik Ivars collaborates with notable colleagues such as Per Bjork and Tomas Leanderson. These partnerships enhance the research and development efforts at Active Biotech AB, fostering an environment of innovation and discovery.
Conclusion
Frederik Ivars is a prominent inventor whose work in therapeutic compound development is paving the way for future medical advancements. His contributions, particularly through his patent on the S100A9 interaction screening method, highlight the importance of innovation in the field of medicine.